US Patent 12122834 Anti-PD-1 antibodies
Patent 12122834 was granted and assigned to Merck Sharp & Dohme Limited on October, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+25 properties)
Article (+207 characters)
US Patent 12122834 Anti-PD-1 antibodies
Article
Patent abstract
The present invention relates to anti-PD-1 antibodies and antigen-binding fragments, and use of these antibodies and antigen-binding fragments in the treatment of cancer or infectious disease.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Hua Ying0
Laurence Fayadat-Dilman0
Shaopeng Huang0
Shireen Khan0
Veronica Juan0
Date of Patent
October 22, 2024
0Patent Application Number
169656160
Date Filed
January 31, 2019
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 12122834 Anti-PD-1 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
